Eisai CEO retires

Share this article:

Eisai's president and CEO Lonnel Coats is retiring. The company announced Monday that Coats will leave the company in June, but will hand off his titles April 1, the first day of the company's new fiscal year.

Yuji Matsue will be the new chairman and CEO and will oversee “the strategic direction of the Americas Region.” Shaji Procida, the new president and COO as of April 1, will “have full operating responsibility for the US Business.”

The new executive lineup accompanies an organizational change that also goes into effect April 1. The company noted in its third-quarter earnings for FY 2014 that the pharmaceutical businesses will be designated as follows in FY2015: Japan (prescription drugs, generic drugs and diagnostics), Americas (North, Central and South), Asia (China, South Korea, Taiwan, India and ASEAN), EMEA (Europe, Middle East, Africa and Oceania) and Consumer Healthcare Businesses.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.